In News:

Every year, March 24 is observed as World Tuberculosis (TB) Day to commemorate Dr. Robert Koch’s 1882 discovery of Mycobacterium tuberculosis.

For 2026, the World Health Organization (WHO) has retained the theme “Yes! We can End TB!”, signaling a shift from global ambition to localized, high-impact action.

In India, the day serves as a critical checkpoint for the National TB Elimination Programme (NTEP). While India missed its audacious 2025 elimination deadline, the focus has now pivoted toward aggressive "mission-mode" strategies to bridge the remaining gaps.

The Current Status of TB in India

India’s TB landscape is a study in contrasts—significant statistical improvements set against a backdrop of a staggering absolute burden.

• Global Burden: India accounts for approximately 25% of global TB cases and 28% of global TB deaths.
• Key Progress Indicators (2015–2024):
  • Incidence: Declined by 21%.
  • Mortality: Reduced from 28 per lakh (2015) to 21 per lakh (2024).
  • Treatment Coverage: Increased dramatically from 53% to 92%.
  • Success Rate: Under the Pradhan Mantri TB Mukt Bharat Abhiyan, the success rate reached 90%, surpassing the global average of 88%.
• The "Missing Cases" Challenge: Despite these gains, nearly one lakh cases remain undiagnosed annually, contributing to 8.8% of the global detection gap.

Evolution of India's Strategy: From Control to Elimination

India transitioned from the Revised National TB Control Programme (RNTCP) to the National TB Elimination Programme (NTEP) in 2020. The programme is anchored by the National Strategic Plan (2017–2025) and the Detect–Treat–Prevent–Build (DTPB) framework.

Major Technological and Medical Advancements:

• Molecular Diagnostics: India operates the world’s largest TB lab network; 92% of patients now receive upfront Rifampicin drug-resistance testing, ensuring they aren't started on ineffective first-line drugs.
• BPaLM Regimen: The introduction of the BPaLM (Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin) regimen has revolutionized Multi-Drug Resistant (MDR) TB care, reducing treatment duration from 18–24 months to just 6 months.
• Digital Ecosystem: The Ni-kshay portal and the newly launched TB Mukt Bharat App facilitate real-time patient tracking and treatment adherence.

Social and Nutritional Support: The Ni-kshay Ecosystem

Recognizing that TB is as much a social disease as a biological one, India has integrated nutrition and community support into the clinical cycle:

• Ni-kshay Poshan Yojana (NPY): Financial support has been increased to ?1,000/month, providing a total of ?3,000 to ?6,000 over the treatment course.
• Ni-kshay Mitras: A unique "crowdsourced" healthcare model where citizens and corporates "adopt" TB patients to provide monthly food baskets and vocational support.

Critical Gaps and Strengthening Measures

To achieve the definition of elimination (less than one notified case per million population per year), India must address the following:

• Active Case Finding (ACF) for Subclinical TB: Nearly half of India's TB cases are subclinical (asymptomatic). Mass rollout of AI-enabled portable Chest X-rays and non-invasive tongue swabs is essential to find "silent" transmitters.
• Tribal-Centric Interventions: TB prevalence among Scheduled Tribes is 50% higher than the national average. Innovative financing, such as utilizing District Mineral Foundation (DMF) funds, can bridge the infrastructure gap in mining-affected tribal belts.
• TB Preventive Treatment (TPT): Shifting focus to household contacts of active patients to treat the infection in its latent stage before it progresses to active disease.
• Urban Micro-strategies: High-transmission urban wards require "micro-level" interventions through initiatives like the TB Mukt Urban Ward.